ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway.

Yongsheng Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.